We found that IGFBP3 serum levels in PXE and control sera showed no significant difference with age, but a significant increase in PXE patients over 45 years compared to the appropriate control cohort. This evidence concerns the gene IGFBP3 and pseudoxanthoma elasticum (inherited or acquired).